Fibrin accumulation secondary to loss of plasmin-mediated fibrinolysis drives inflammatory osteoporosis in mice.

PubWeight™: 0.82‹?›

🔗 View Article (PMC 4474376)

Published in Arthritis Rheumatol on August 01, 2014

Authors

Heather A Cole1, Tetsuro Ohba, Jeffry S Nyman, Haro Hirotaka, Justin M M Cates, Matthew J Flick, Jay L Degen, Jonathan G Schoenecker

Author Affiliations

1: Vanderbilt University Medical Center, Nashville, Tennessee.

Articles cited by this

Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev (2000) 6.42

Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med (1995) 5.27

Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest (2005) 5.19

Impaired wound healing in mice with a disrupted plasminogen gene. Nat Med (1996) 4.72

Mechanisms of anabolic therapies for osteoporosis. N Engl J Med (2007) 3.33

Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice. Genes Dev (1995) 3.27

Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency. Cell (1996) 2.72

Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo. J Clin Invest (2004) 2.57

Osteoporosis in patients with diabetes mellitus. J Bone Miner Res (2007) 2.27

Osteoporosis and inflammation. Nutr Rev (2007) 2.21

The fibrin-derived gamma377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease. J Exp Med (2007) 2.16

Fibrinogen as a key regulator of inflammation in disease. Semin Immunopathol (2011) 2.14

Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation. Nat Commun (2012) 1.82

Bone versus immune system. Nature (2000) 1.78

A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. Biochem Biophys Res Commun (1999) 1.72

The role of proteases in transforming growth factor-beta activation. Int J Biochem Cell Biol (2007) 1.67

Gut, inflammation and osteoporosis: basic and clinical concepts. Gut (2008) 1.61

Effect of cigarette smoking on lipids, lipoproteins, blood coagulation, fibrinolysis and cellular components of human blood. Atherosclerosis (1975) 1.46

Osteoporosis, inflammation and ageing. Immun Ageing (2005) 1.40

Proteinases in cutaneous wound healing. Cell Mol Life Sci (2009) 1.36

Coagulation and fibrinolysis abnormalities in obesity. J Endocrinol Invest (2002) 1.29

Fibrinogen activates NF-kappa B transcription factors in mononuclear phagocytes. J Immunol (1998) 1.28

Characterization of the IL-6 responsive elements in the gamma fibrinogen gene promoter. J Biol Chem (1995) 1.25

Obesity and fracture in men and women: an epidemiologic perspective. J Bone Miner Res (2012) 1.24

Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption. Clin Lab (2006) 1.22

Colitis-associated cancer is dependent on the interplay between the hemostatic and inflammatory systems and supported by integrin alpha(M)beta(2) engagement of fibrinogen. Cancer Res (2010) 1.21

Osteoporosis and inflammation. Arq Bras Endocrinol Metabol (2010) 1.17

The continuing saga of complement receptor type 3 (CR3) J Clin Invest (1996) 1.15

Coagulation and fibrinolysis in diabetes. Diab Vasc Dis Res (2010) 1.12

Plasmin modulates vascular endothelial growth factor-A-mediated angiogenesis during wound repair. Am J Pathol (2006) 1.09

Fibrinogen and fibrin induce synthesis of proinflammatory cytokines from isolated peripheral blood mononuclear cells. Thromb Haemost (2007) 1.03

Disturbance of the OPG/RANK/RANKL pathway and systemic inflammation in COPD patients with emphysema and osteoporosis. Respir Res (2011) 0.96

Osteoporosis and smoking. JAMA (1972) 0.94

Amelioration of Duchenne muscular dystrophy in mdx mice by elimination of matrix-associated fibrin-driven inflammation coupled to the αMβ2 leukocyte integrin receptor. Hum Mol Genet (2012) 0.89

The role of fibrinogen and fibrinolysis in peripheral arterial disease. Thromb Res (2007) 0.87

Plasminogen/plasmin modulates bone metabolism by regulating the osteoblast and osteoclast function. J Biol Chem (2011) 0.85

Immune changes in post-menopausal osteoporosis: the Immunos study. Osteoporos Int (2009) 0.84

Effect of cigarette smoking on plasma fibrin clot permeability and susceptibility to lysis. Thromb Haemost (2009) 0.84

Inflammation-induced osteoporosis. The IMO model. Methods Mol Med (2003) 0.82

Osteoprotegerin, leptin and IL-6: association with silent myocardial ischemia in type 2 diabetes mellitus. Diab Vasc Dis Res (2012) 0.81

Fibrinogen and fibrin clot structure in diabetes. Herz (2004) 0.80

Coagulopathies in orthopaedics: links to inflammation and the potential of individualizing treatment strategies. J Orthop Trauma (2013) 0.79

Articles by these authors

Cerebral ischemia-hypoxia induces intravascular coagulation and autophagy. Am J Pathol (2006) 3.18

Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood (2004) 3.13

Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo. J Clin Invest (2004) 2.57

The fibrin-derived gamma377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease. J Exp Med (2007) 2.16

The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling. J Clin Invest (2008) 2.11

The thrombomodulin-protein C system is essential for the maintenance of pregnancy. Nat Med (2003) 1.98

Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation. Nat Commun (2012) 1.82

Fibrinogen triggers astrocyte scar formation by promoting the availability of active TGF-beta after vascular damage. J Neurosci (2010) 1.82

Characterization of 1H NMR signal in human cortical bone for magnetic resonance imaging. Magn Reson Med (2010) 1.82

Fibrinogen is required for maintenance of platelet intracellular and cell-surface P-selectin expression. Blood (2009) 1.79

Fibrinogen drives dystrophic muscle fibrosis via a TGFbeta/alternative macrophage activation pathway. Genes Dev (2008) 1.73

The development of inflammatory joint disease is attenuated in mice expressing the anticoagulant prothrombin mutant W215A/E217A. Blood (2011) 1.71

Fibrinogen, acting as a mitogen for tubulointerstitial fibroblasts, promotes renal fibrosis. Kidney Int (2011) 1.70

Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms. Blood (2007) 1.65

Spontaneous hematogenous and lymphatic metastasis, but not primary tumor growth or angiogenesis, is diminished in fibrinogen-deficient mice. Cancer Res (2002) 1.64

Primary leiomyosarcoma of extragnathic bone: clinicopathologic features and reevaluation of prognosis. Arch Pathol Lab Med (2009) 1.63

Silent information regulator (Sir)T1 inhibits NF-κB signaling to maintain normal skeletal remodeling. J Bone Miner Res (2013) 1.54

Fibrin(ogen) exacerbates inflammatory joint disease through a mechanism linked to the integrin alphaMbeta2 binding motif. J Clin Invest (2007) 1.52

Clinically compatible MRI strategies for discriminating bound and pore water in cortical bone. Magn Reson Med (2012) 1.38

Non-invasive predictors of human cortical bone mechanical properties: T(2)-discriminated H NMR compared with high resolution X-ray. PLoS One (2011) 1.37

Cigarette smoke extract induces thymic stromal lymphopoietin expression, leading to T(H)2-type immune responses and airway inflammation. J Allergy Clin Immunol (2008) 1.30

The use of nanoindentation for characterizing the properties of mineralized hard tissues: state-of-the art review. J Biomed Mater Res B Appl Biomater (2008) 1.27

Plasmin(ogen) promotes renal interstitial fibrosis by promoting epithelial-to-mesenchymal transition: role of plasmin-activated signals. J Am Soc Nephrol (2007) 1.25

Colitis-associated cancer is dependent on the interplay between the hemostatic and inflammatory systems and supported by integrin alpha(M)beta(2) engagement of fibrinogen. Cancer Res (2010) 1.21

Fibrin(ogen)-alpha M beta 2 interactions regulate leukocyte function and innate immunity in vivo. Exp Biol Med (Maywood) (2004) 1.20

Platelet TGF-β1 contributions to plasma TGF-β1, cardiac fibrosis, and systolic dysfunction in a mouse model of pressure overload. Blood (2011) 1.20

Factor XIII activity mediates red blood cell retention in venous thrombi. J Clin Invest (2014) 1.18

Antithrombotic thrombocytes: ectopic expression of urokinase-type plasminogen activator in platelets. Blood (2003) 1.18

Inhibition of TGF-β signaling by 1D11 antibody treatment increases bone mass and quality in vivo. J Bone Miner Res (2010) 1.15

Mice with a selective impairment of IFN-gamma signaling in macrophage lineage cells demonstrate the critical role of IFN-gamma-activated macrophages for the control of protozoan parasitic infections in vivo. J Immunol (2009) 1.14

Type 1 diabetes in young rats leads to progressive trabecular bone loss, cessation of cortical bone growth, and diminished whole bone strength and fatigue life. J Bone Miner Res (2009) 1.14

Aluminum adjuvants elicit fibrin-dependent extracellular traps in vivo. Blood (2010) 1.12

Validation of quantitative bound- and pore-water imaging in cortical bone. Magn Reson Med (2013) 1.12

Genetic elimination of prothrombin in adult mice is not compatible with survival and results in spontaneous hemorrhagic events in both heart and brain. Blood (2008) 1.11

Genetic and pharmacological modifications of thrombin formation in apolipoprotein e-deficient mice determine atherosclerosis severity and atherothrombosis onset in a neutrophil-dependent manner. PLoS One (2013) 1.11

Transforming growth factor β suppresses osteoblast differentiation via the vimentin activating transcription factor 4 (ATF4) axis. J Biol Chem (2012) 1.10

Reduced thrombin generation increases host susceptibility to group A streptococcal infection. Blood (2008) 1.10

Protease-activated receptor-2 signaling triggers dendritic cell development. Am J Pathol (2003) 1.09

Anti-transforming growth factor ß antibody treatment rescues bone loss and prevents breast cancer metastasis to bone. PLoS One (2011) 1.08

Mice lacking Nf1 in osteochondroprogenitor cells display skeletal dysplasia similar to patients with neurofibromatosis type I. Hum Mol Genet (2011) 1.06

Micro-computed tomography assessment of the progression of fracture healing in mice. Bone (2012) 1.06

The effects of rhBMP-2 released from biodegradable polyurethane/microsphere composite scaffolds on new bone formation in rat femora. Biomaterials (2009) 1.05

Genetic elimination of the binding motif on fibrinogen for the S. aureus virulence factor ClfA improves host survival in septicemia. Blood (2013) 1.03

Deleterious effects of plasminogen activators in neonatal cerebral hypoxia-ischemia. Am J Pathol (2008) 1.01

Necroinflammatory liver disease in BALB/c background, TGF-beta 1-deficient mice requires CD4+ T cells. J Immunol (2003) 1.01

A possible role for TSLP in inflammatory arthritis. Biochem Biophys Res Commun (2007) 1.00

Thrombomodulin is a determinant of metastasis through a mechanism linked to the thrombin binding domain but not the lectin-like domain. Blood (2011) 1.00

Binding of Efb from Staphylococcus aureus to fibrinogen blocks neutrophil adherence. J Biol Chem (2011) 0.99

A novel approach to assess post-yield energy dissipation of bone in tension. J Biomech (2007) 0.99

Antibody blockade or mutation of the fibrinogen gamma-chain C-terminus is more effective in inhibiting murine arterial thrombus formation than complete absence of fibrinogen. Blood (2003) 0.99

Raman and mechanical properties correlate at whole bone- and tissue-levels in a genetic mouse model. J Biomech (2010) 0.98

Plasminogen supports tumor growth through a fibrinogen-dependent mechanism linked to vascular patency. Blood (2003) 0.97

Control of thrombus embolization and fibronectin internalization by integrin alpha IIb beta 3 engagement of the fibrinogen gamma chain. Blood (2003) 0.97

Orally administered TGF-beta is biologically active in the intestinal mucosa and enhances oral tolerance. J Allergy Clin Immunol (2007) 0.96

Polarization control of Raman spectroscopy optimizes the assessment of bone tissue. J Biomed Opt (2013) 0.94

Fibrin but not adsorbed fibrinogen supports fibronectin assembly by spread platelets. Effects of the interaction of alphaIIb beta3 with the C terminus of the fibrinogen gamma-chain. J Biol Chem (2005) 0.93

Bmp2 in osteoblasts of periosteum and trabecular bone links bone formation to vascularization and mesenchymal stem cells. J Cell Sci (2013) 0.92

β2-Adrenergic receptor signaling in osteoblasts contributes to the catabolic effect of glucocorticoids on bone. Endocrinology (2011) 0.91

Urokinase-type plasminogen activator supports liver repair independent of its cellular receptor. BMC Gastroenterol (2006) 0.91

Methylthioadenosine phosphorylase and activated insulin-like growth factor-1 receptor/insulin receptor: potential therapeutic targets in chordoma. J Pathol (2010) 0.91

Fibrinolysis is essential for fracture repair and prevention of heterotopic ossification. J Clin Invest (2015) 0.91

Thymic stromal lymphopoietin secretion of synovial fibroblasts is positively and negatively regulated by Toll-like receptors/nuclear factor-kappaB pathway and interferon-gamma/dexamethasone. Mod Rheumatol (2007) 0.90

Plasminogen directs the pleiotropic effects of uPA in liver injury and repair. Am J Physiol Gastrointest Liver Physiol (2002) 0.90

Soft tissue perineurioma in a patient with neurofibromatosis type 2: a tumor not previously associated with the NF2 syndrome. Am J Surg Pathol (2006) 0.90

Administration of factor XIII B subunit increased plasma factor XIII A subunit levels in factor XIII B subunit knock-out mice. Int J Hematol (2007) 0.90

Occult primary. J Natl Compr Canc Netw (2011) 0.90

Prognostic significance of c-Myc expression in soft tissue leiomyosarcoma. Mod Pathol (2009) 0.90

Fibrin(ogen)-independent role of plasminogen activators in acetaminophen-induced liver injury. Am J Pathol (2012) 0.89

Amelioration of Duchenne muscular dystrophy in mdx mice by elimination of matrix-associated fibrin-driven inflammation coupled to the αMβ2 leukocyte integrin receptor. Hum Mol Genet (2012) 0.89

Mechanisms coupling the hemostatic system to colitis-associated cancer. Thromb Res (2010) 0.89

Bisphosphonates inhibit osteosarcoma-mediated osteolysis via attenuation of tumor expression of MCP-1 and RANKL. J Bone Miner Res (2014) 0.89

Mechanisms linking tumor cell-associated procoagulant function to tumor metastasis. Thromb Res (2007) 0.89

Prostate cancer metastases alter bone mineral and matrix composition independent of effects on bone architecture in mice--a quantitative study using microCT and Raman spectroscopy. Bone (2013) 0.88

Plasmin-mediated proteolysis is required for hepatocyte growth factor activation during liver repair. J Biol Chem (2009) 0.88

Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts. J Bone Miner Res (2010) 0.88

MHC-independent genetic regulation of liver damage in a mouse model of autoimmune hepatocellular injury. Lab Invest (2005) 0.88

Plasmin deficiency does not alter endogenous murine amyloid beta levels in mice. Neurosci Lett (2004) 0.88

Synthesis, characterization, and remodeling of weight-bearing allograft bone/polyurethane composites in the rabbit. Acta Biomater (2010) 0.87

Integrated system for combined Raman spectroscopy-spectral domain optical coherence tomography. J Biomed Opt (2011) 0.87

Early detection of thrombin activity in neuroinflammatory disease. Ann Neurol (2014) 0.87

Deficiency in metabolic regulators PPARγ and PTEN cooperates to drive keratinizing squamous metaplasia in novel models of human tissue regeneration. Am J Pathol (2012) 0.87

Novel function of TWEAK in inducing intervertebral disc degeneration. J Orthop Res (2007) 0.86

Hepatic to pancreatic switch defines a role for hemostatic factors in cellular plasticity in mice. Proc Natl Acad Sci U S A (2005) 0.85

Transdermal lovastatin enhances fracture repair in rats. J Bone Miner Res (2008) 0.85

Microscope sterility during spine surgery. Spine (Phila Pa 1976) (2012) 0.84

The Role of Water Compartments in the Material Properties of Cortical Bone. Calcif Tissue Int (2015) 0.84